Tag: Health and Medical
-
Rescindo Therapeutics’ RSC-57 Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Kabuki Syndrome
CARY, N.C. — Rescindo Therapeutics Inc., a drug discovery company dedicated to the development of new treatments for rare genetic disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Rare Pediatric Disease Designation for the Company’s lead drug RSC-57, for the treatment of patients with Kabuki Syndrome.
-
JNL Technologies Launches Quantum SA Standalone Wander Management Control Unit
IXONIA, Wis. — JNL Technologies, maker of Quantum nurse call, wander management, and access control systems, is now shipping Quantum SA, a standalone wander management system. Using the same proven Bluetooth technology as JNL’s Quantum DCS product line, the Quantum SA does not require cable installation or the purchase of a Quantum server and is…
-
Flightpath Biosciences Launches via Illumina Accelerator to Conduct Largest Clinical Biomarker Study in Lyme Disease
BERKELEY, Calif. — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of…
-
Kalyagen Announces Launch of ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
AUSTIN, Texas — Kalyagen is pleased to announce the launch of its “Stem the Tide of Time” social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
-
Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients
AUSTIN, Texas — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,”…
-
EPIC Insurance Brokers & Consultants Acquires Pharmaceutical Strategies Group
SAN FRANCISCO, Calif. — EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into EPIC’s Employee Benefits Consulting practice.
-
Pure Protein, LLC and Pure Transplant Solutions, LLC Promote Blake Harlan to President and Dr. Rico Buchli to Vice President of Products and Services
AUSTIN, Texas — Pure Protein, LLC (Pure Protein) and subsidiary company Pure Transplant Solutions, LLC (PTS), announced today that Blake Harlan has been promoted to President and Rico Buchli, PhD to Vice President of Products and Services.
-
Coral Springs Medical & Dental Takes Industry-Leading Approach to Healthcare
CORAL SPRINGS, Fla. — HG Doctors recently added a third location to its family of healthcare practices – Coral Springs Medical & Dental. Its one-stop approach to healthcare services is a driving force behind its expansion. This new facility offers primary care/family medicine, geriatrics, senior activities, behavioral health, podiatry and dental care – all under…
-
Blockit COVID-19 Operations Platform Powers Big City Vaccination
MCKINNEY, Texas — Blockit Inc., a leading provider of digital care coordination solutions, has been on the front lines of the pandemic, providing a no-cost adaptation of their deeply integrated and highly sophisticated healthcare scheduling platform to be utilized toward COVID-19 relief efforts. Today, Blockit announced that its vaccine scheduling solution is now being used…